Noom In The News
Press
For all press inquiries, contact comms@noom.com.
If you have a question about your account, please contact our Support team.
Press

Noom launches full-page ad in Wall Street Journal advocating for policy changes regarding compounded GLP-1s

Online GLP-1 Sales Fuel Hormone Replacement Therapy

Noom Launches HRT Program for Menopause Support

Noom Enters HRT Space

A digital health care app is using AI body scans to stop muscle loss from weight-loss drugs

Mount Sinai partners with Princeton-based weight-loss startup

Noom to offer compounded GLP-1 drug to rival pricey branded weight loss meds

Another digital healthcare company is selling off-brand weight loss drugs — for pretty cheap

Digital health company Noom to offer compounded GLP-1 drug through new weight loss program
In The News
Noom appoints Dr. Jeffrey Egler as Chief Medical Officer to Lead Innovation in Healthy Aging and Longevity
NEW YORK, April 07, 2025 -- Noom, the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, announced today that Dr. Jeffrey Egler will be joining as the new Chief Medical Officer (CMO). Dr. Egler’s...
Noom To Streamline Access to Zepbound® Vials with Noom GLP-1 Companion Through Integration with LillyDirect® Pharmacy Provider
New York, NY – March 31, 2025 – Noom, the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, today announced an agreement with Eli Lilly and Company’s LillyDirect® pharmacy provider, Gifthealth,...
Noom Expands into Hormone Replacement Therapy to Support Women’s Health and Well-being
Noom + HRTRx blends Noom’s proven behavior change program with HRT medication to achieve whole-person health The new offering builds on the rapid growth of the company’s medically assisted weightloss franchise, which combines healthy habits with accessible medications...
Noom Introduces Free AI-Powered Personalized Health Report to Promote Living Better Longer
New Body Age Prediction and Existing Body Composition Analysis Now Available to Everyone, Including Free Members of Noom Noom, the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, today unveiled...
Noom’s GLP-1 Companion Receives Major Update to Prepare for New Expected Prescription Drug Use-Related Software (PDURS) Model
Noom releases a significant update of its innovative GLP-1 companion to improve medication persistence and adherence while decreasing side effect prevalence and improving lean mass preservation and weight loss outcomes. New app features include Medication Tracking...
Noom Offers Oral Medications For Weight Loss Starting at $29
A $29 entry price helps provide accessibility for people pursuing weight loss goals Service includes all features of Noom Med with asynchronous telehealth doctor visits, access to care coordinators, Noom Premium 1:1 Coaching and more Provides a weight loss medication...
Noom Unveils Two New Enterprise Products to Help Employers Offer, Manage, and Effectively Control GLP-1 Expenses
Noom Med with SmartRx, in partnership with Waltz Health, drives significant ROI for employers who wish to cover GLP-1s as a supplemental benefit such that the payer can choose the level of financial assistance they will provide Noom Weight with GLP-1Rx delivers...
Noom Introduces Innovative In-App Body Scan Technology to Monitor Muscle-Mass Retention During GLP-1 Treatment
Technology enhances Noom GLP-1 Companion with Muscle Defense™, helping users measure and track progress with a smartphone camera and avoid conditions like sarcopenic obesity October 17, 2024 — New York, NY — Noom, the leading digital healthcare company committed to...
Noom Strengthens Healthcare Team by Adding Women’s Health Experts
Julia Edelman, MD, joins as Executive Director of Women’s Health and Karen Mann, MD, joins Noom as Medical Director Noom, the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, is pleased to announce...